Literature DB >> 15851615

Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor.

Young-sup Yoon1, Shigeki Uchida, Osamu Masuo, Manfred Cejna, Jong-Seon Park, Hyeon-cheol Gwon, Rudolf Kirchmair, Ferdinand Bahlman, Dirk Walter, Cynthia Curry, Allison Hanley, Jeffrey M Isner, Douglas W Losordo.   

Abstract

BACKGROUND: Diabetic cardiomyopathy (DCM) is characterized by microvascular pathology and interstitial fibrosis, which leads to progressive heart failure; however, the pathogenesis of DCM remains uncertain. METHODS AND
RESULTS: Using the streptozotocin-induced diabetic rat model, we evaluated the natural course of DCM over a period of 1 year by serial echocardiography, Western blot analysis for vascular endothelial growth factor (VEGF), endothelial progenitor cell assays, myocardial blood flow measurements, and histopathologic analysis that included terminal dUTP nick end-labeling (TUNEL), capillary and cardiomyocyte density, and fibrosis area. Downregulation of myocardial VEGF expression preceded all other features of DCM and was followed by increased apoptosis of endothelial cells, decreased numbers of circulating endothelial progenitor cells, decreased capillary density, and impaired myocardial perfusion. Apoptosis and necrosis of cardiomyocytes ensued, along with fibrosis and progressive diastolic and then systolic dysfunction. To provide further evidence of the central role of VEGF in the pathophysiology of DCM, we replenished myocardial VEGF expression using naked DNA gene therapy via direct intramyocardial injection of plasmid DNA encoding VEGF (phVEGF165). VEGF-replenished rats showed increased capillary density, decreased endothelial cell and cardiomyocyte apoptosis, and in situ differentiation of bone marrow-derived endothelial progenitor cells into endothelial cells. These anatomic findings were accompanied by significant improvements in cardiac function.
CONCLUSIONS: These findings suggest that downregulation of VEGF may compromise microvascular homeostasis in the myocardium and thereby play a central role in the pathogenesis of DCM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851615     DOI: 10.1161/01.CIR.0000162472.52990.36

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  115 in total

1.  The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.

Authors:  Zuyue Sun; Jill Schriewer; Mingxin Tang; Jerry Marlin; Frederick Taylor; Ralph V Shohet; Eugene A Konorev
Journal:  J Mol Cell Cardiol       Date:  2015-12-11       Impact factor: 5.000

Review 2.  Diabetic cardiomyopathy: where are we 40 years later?

Authors:  V Sharma; John H McNeill
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

Review 3.  What is the efficiency of ATP signaling from erythrocytes to regulate distribution of O(2) supply within the microvasculature?

Authors:  Christopher G Ellis; Stephanie Milkovich; Daniel Goldman
Journal:  Microcirculation       Date:  2012-07       Impact factor: 2.628

4.  MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes.

Authors:  Fang Zhao; Bo Li; Yin-Zhi Wei; Bin Zhou; Han Wang; Ming Chen; Xue-Dong Gan; Zhao-Hui Wang; Shi-Xi Xiong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-12-13

5.  Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.

Authors:  Annayya R Aroor; James R Sowers; Shawn B Bender; Ravi Nistala; Mona Garro; Irina Mugerfeld; Melvin R Hayden; Megan S Johnson; Muhammad Salam; Adam Whaley-Connell; Vincent G Demarco
Journal:  Endocrinology       Date:  2013-05-07       Impact factor: 4.736

Review 6.  Coronary vessel development and insight towards neovascular therapy.

Authors:  Nicola Smart; Karina N Dubé; Paul R Riley
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

7.  Dual angiogenic and neurotrophic effects of bone marrow-derived endothelial progenitor cells on diabetic neuropathy.

Authors:  Jin-Ok Jeong; Mee-Ohk Kim; Hyongbum Kim; Min-Young Lee; Sung-Whan Kim; Masaaki Ii; Jung-uek Lee; Jiyoon Lee; Yong Jin Choi; Hyun-Jai Cho; Namho Lee; Marcy Silver; Andrea Wecker; Dong-Wook Kim; Young-sup Yoon
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

8.  Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats.

Authors:  G P Fadini; S Sartore; M Schiavon; M Albiero; I Baesso; A Cabrelle; C Agostini; A Avogaro
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

Review 9.  Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.

Authors:  Michael Zeisberg; Raghu Kalluri
Journal:  Am J Physiol Cell Physiol       Date:  2012-12-19       Impact factor: 4.249

10.  Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles.

Authors:  Andrea Caporali; Elisabetta Pani; Anton J G Horrevoets; Nicolle Kraenkel; Atsuhiko Oikawa; Graciela B Sala-Newby; Marco Meloni; Brunella Cristofaro; Gallia Graiani; Aurelie S Leroyer; Chantal M Boulanger; Gaia Spinetti; Sung Ok Yoon; Paolo Madeddu; Costanza Emanueli
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.